TNDM 241220 30.00P (TNDM241220P30000) Stock Options, News & Quotes

US OptionsDetailed Quotes

TNDM241220P30000

Watchlist

0.80
-0.55-40.74%

15min DelayClose Dec 2 16:00 ET

0.80High0.75Low

Intraday

5D
Daily

News

Morgan Stanley Bullish on Medtech in 2025, Upgrades 5 Stocks
Seeking Alpha16:12 ET
Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos
Benzinga14:29 ET
Tandem Diabetes Care Raised to Overweight From Equal-Weight by Morgan Stanley
Dow JonesDec 2 09:11 ET · Ratings
Morgan Stanley Upgrades Tandem Diabetes Care(TNDM.US) to Buy Rating, Maintains Target Price $45
Moomoo NewsDec 2 06:31 ET · Ratings
Leerink Partners Keeps Their Buy Rating on Tandem Diabetes Care (TNDM)
TipRanksNov 28 04:26 ET · Ratings
Express News | Tandem Diabetes Care Inc : Leerink Partners Cuts Target Price to $58 From $59
ReutersNov 25 07:23 ET

Comments

mad541

Aug 2 11:48

company needs money this always drops 35% after earnings I'm out

mad541

Aug 2 11:46

$Tandem Diabetes Care (TNDM.US)$ company needs money this always drops 35% after earnings I'm out 🩸🩸🩸

Trytosaveabit

Aug 1 15:13

Update

$Tandem Diabetes Care (TNDM.US)$ Second Quarter 2024 Highlights
-- Worldwide GAAP sales increased 13 percent to $221.9 million compared to
second quarter 2023; worldwide non-GAAP sales(1) increased 12 percent to
$221.8 million compared to second quarter 2023.
-- More than 20,000 pumps shipped in the United States, a sequential
increase of 33 percent compared to first quarter 2024.
-- Launched Tandem Mobi with Dexcom G7 continuous glucose monitoring (CGM)
sensor integration in th...

70862468

May 21 11:11

Stock moves

$Tandem Diabetes Care (TNDM.US)$
Just check call options. they are expensive
However, stock price moves only 5-10% with no news. Something is going on behind the scene?!

Moomoo AI

Mar 22 05:56

Despite losses and negative cash flow, the company's US$178.2m balance sheet allows for at least two years of growth spending. However, the stock is seen as risky due to these financial conditions.

Is Tandem Diabetes Care (NASDAQ:TNDM) Using Debt In A Risky Way?